regenexx
-
Biologics
BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
— Intellectual Property Provides a Cell-Based Therapeutic Platform Designed to Target All Avascular Zones— MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE)…
Read More » -
Biologics
Regenexx Publishes Mid-term Results of Its Randomized Controlled Trial Showing Its Perc-ACLR Procedure Can Help Patients Avoid Surgical ACL Reconstruction
DES MOINES, Iowa, Aug. 10, 2022 /PRNewswire/ — Regenexx®, a research-driven interventional orthobiologics network of physicians performing regenerative orthopedic procedures, has published…
Read More » -
Biologics
Published Regenexx Research, Involving Stem Cells And Platelets, Shows Promise For Treating Osteoarthritis Of The Knee
BROOMFIELD, Colo., Dec, 21, 2018 /PRNewswire/ — New research from Regenexx®, which provides advanced interventional orthobiologics, shows greater potential for treating…
Read More » -
Spine
SpineMark Announces a Strategic Partnership With Regenexx
SAN DIEGO (PRWEB) JULY 03, 2018 SpineMark is the premier global spine service company for the development of Spine Destination Centers…
Read More » -
Biologics
Regenexx Publishes New Research Findings That May Help Alleviate the Opioid Crisis
January 16, 2018 BROOMFIELD, Colo.–(BUSINESS WIRE)–A significant number of opioid deaths worldwide involve patients who become addicted to prescription narcotics…
Read More » -
Biologics
Regenexx Announces Successful Merger with Harbor View Medical
July 11, 2017 BROOMFIELD, Colo.–(BUSINESS WIRE)–Regenexx, a Colorado-based stem-cell-treatment network and pioneer in the invention of interventional orthopedics, today announced…
Read More » -
Spine
Reports of the Death of the C1-C2 Facet Injection have Been Greatly Exaggerated
By Chris Centeno, M.D., CEO at Regenexx – April 16, 2017 In 1897, Mark Twain was on a speaking tour in…
Read More » -
Biologics
Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain
BROOMFIELD, Colo., April 17, 2017 /PRNewswire/ — “Interventional orthopedics in pain medicine practice” was recently published by Elsevier as a…
Read More » -
Biologics
Regenexx® Releases Patient Outcomes Application for Orthopedic Stem Cell Treatments
BROOMFIELD, Colo., Dec. 13, 2016 /PRNewswire/ — Regenexx, a Colorado-based stem-cell-treatment network and pioneer in the invention of orthopedic stem cell…
Read More » -
Hospitals
Regenexx® Announces Issue of United States Patent on Proprietary Orthopedic Stem Cell Procedure
DENVER, Oct. 28, 2015 /PRNewswire/ — Regenexx® today announced the recent issue of a US Patent on their proprietary same day stem cell…
Read More » -
Colorado Medical Clinic Welcomes Opportunity to Fight FDA in Court
DENVER, Aug. 9 /PRNewswire/ — Regenerative Sciences, Inc., a Colorado medical practice that specializes in the use of a person’s own stem cells to help…
Read More »